These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401 [TBL] [Abstract][Full Text] [Related]
10. Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. de Veer RC; Harms MH; Corpechot C; Thorburn D; Invernizzi P; Janssen HLA; Battezzati PM; Nevens F; Lindor KD; Floreani A; Ponsioen CY; Mayo MJ; Parés A; Mason AL; Kowdley KV; Trivedi PJ; Hirschfield GM; Bruns T; Dalekos GN; Gatselis NK; Verhelst X; Lammers WJ; Hansen BE; van Buuren HR; van der Meer AJ; Aliment Pharmacol Ther; 2022 Nov; 56(9):1408-1418. PubMed ID: 36138566 [TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. Harms MH; van Buuren HR; Corpechot C; Thorburn D; Janssen HLA; Lindor KD; Hirschfield GM; Parés A; Floreani A; Mayo MJ; Invernizzi P; Battezzati PM; Nevens F; Ponsioen CY; Mason AL; Kowdley KV; Lammers WJ; Hansen BE; van der Meer AJ J Hepatol; 2019 Aug; 71(2):357-365. PubMed ID: 30980847 [TBL] [Abstract][Full Text] [Related]
12. Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis. Harms MH; de Veer RC; Lammers WJ; Corpechot C; Thorburn D; Janssen HLA; Lindor KD; Trivedi PJ; Hirschfield GM; Pares A; Floreani A; Mayo MJ; Invernizzi P; Battezzati PM; Nevens F; Ponsioen CY; Mason AL; Kowdley KV; Hansen BE; Buuren HRV; van der Meer AJ Gut; 2020 Aug; 69(8):1502-1509. PubMed ID: 31843787 [TBL] [Abstract][Full Text] [Related]
13. A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis. Goet JC; Murillo Perez CF; Harms MH; Floreani A; Cazzagon N; Bruns T; Prechter F; Dalekos GN; Verhelst X; Gatselis NK; Lindor KD; Lammers WJ; Gulamhusein A; Reig A; Carbone M; Nevens F; Hirschfield GM; van der Meer AJ; van Buuren HR; Hansen BE; Parés A; Am J Gastroenterol; 2021 Jul; 116(7):1514-1522. PubMed ID: 33941746 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and Treatment of Primary Biliary Cholangitis]. Kim KA Korean J Gastroenterol; 2023 Feb; 81(2):86-90. PubMed ID: 36824036 [TBL] [Abstract][Full Text] [Related]
15. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis]. Yuan Z; Jia G; Han Y Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931 [TBL] [Abstract][Full Text] [Related]